actiononhearingloss.org.uk
21
We worked to turn discoveries into treatments
•
We funded a multi-disciplinary project to develop a new drug treatment for age-related
and noise-induced hearing loss, which brings together the drug-discovery expertise
of Pragma Therapeutics, and the hearing research expertise of the Global Center for
Hearing and Speech at the University of South Florida.
•
Three companies that we’ve helped are now carrying out clinical trials for new drug
therapies for tinnitus (Auris Medical), age-related hearing loss (Autifony Therapeutics)
and Ménière’s disease (Otonomy).
“Your reports have been a great help to us, in understanding the market
for drugs to treat hearing disorders, right from the early days of Autifony.
They continue to be very useful in providing information to other pharma
companies about the exciting potential for treatments.
Your support for Autifony’s clinical trials – and introductions to experts in
the field – has been extremely valuable.”
Dr Barbara Domayne-Hayman
Chief Business Officer, Autifony Therapeutics Ltd
Action on Hearing Loss
funding has helped us to
identify changes in the
DNA of a gene that make
people prone to middle
ear infection. Eventually,
this should lead to the
development of effective
drug treatments.
Dr Regie Santos-Cortez
Baylor College of Medicine